Science teams and workgroups

Syntheses of potential drugs and studies of structure-activity relationships

Development of Antibacterial, Antifungal and Antituberculosis Drugs

Leader: Prof. PharmDr. Alexandr Hrabálek, CSc.
Development of new potential drugs with antimicrobial activity | Development of new antituberculosis drugs | Synthesis of dexrazoxane analogues and iron chelators

Skin barrier research group

Leader: Prof. PharmDr. Kateřina Vávrová, Ph.D.

Design and Development of New Antimicrobial Agents

Leader: Prof. PharmDr. Martin Doležal, Ph.D.

Synthetic Organic Chemistry and NMR Spectroscopy

Leader: Prof. RNDr. Milan Pour, Ph.D.

Azaphthalocyanine group

Leader: Assoc. Prof. PharmDr. Petr Zimčík, Ph.D.

Pharmaceutical analysis of drugs and other biologically active substances

Analytical Chemistry Group

Leader: Prof. RNDr. Petr Solich, CSc.

Pharmaceutical Analysis Group

Leader: Assoc. Prof. PharmDr. Radim Kučera, Ph.D.

Studies of effects of drugs in various experimental pathological states

Molecular and Cellular Toxicology Group

Leader: Prof. Tomáš Šimůnek, Ph.D.

Research group of Cardiovascular and respiratory pharmacology and toxicology

Leader: Assoc. Prof. PharmDr. Přemysl Mladěnka, Ph.D.
Laboratory of cardiovascular pharmacology | Laboratory of respiratory pharmacology

Workgroup of biological and medical sciences

Leader: Prof. Petr Nachtigal, Ph.D.
Group of pathology and pharmacology of cardiovascular system | Group of clinical physiology of nutrition and metabolism

Analyses of factors determining therapeutic value, consumption and need of drugs after their introduction to clinical practice

Clinical & Social Pharmacy and History of Pharmacy

Leader: Prof. RNDr. Jiří Vlček, CSc.
Pharmacoepidemiology and Clinical Pharmacy
Ageing and Changes in the Therapeutic Value of Medications in the Aged Unit
Integrative and Complementary and Alternative Medicine
History of Health Care and Pharmacy
Social Pharmacy
Research group of compliance-related outcomes